Rhino Novi Inc. has entered into a binding agreement for the purchase of Canada-based BioLife Sciences Corp. BioLife develops, licenses and distributes antibacterial products and non-contact human temperature screening technology. Products include disinfecting wipes, UV sterilization technology, electrostatic disinfection services, anti-microbial textiles and touchless vending/marketplaces.
Rhino Novi acquires BioLife Sciences
Company News | September 8, 2020 | By: ATA
You might also like...
Hainsworth Cue Sports Fabrics signs Ken Doherty as ambassador
Hologenix named Gold Winner of TITAN Innovation Awards
KARL MAYER Reutlingen production site closes, another site to close in December
Reolite receives U.S. EPA, FDA registration for antimicrobial powder technology